Drug Manufacture Failure of Roche’s Gantenerumab in Phase 3 Clinical TrialsBy MohamedMis2July 17, 2023 Roche’s Alzheimer’s drug Gantenerumab has experienced a major setback. It failed phase 3 clinical trials, resulting in financial losses for…
